Home / Drug shortages / Dopamine Hydrochloride Injection

Dopamine Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 11/06/2017. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9252-25
Dosage Form
Injection
Presentation
Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25)
Initial Posting
11/06/2017
Revised Date

Reason

Demand increase for the drug

FDA data resources